Find uplifting stories about heroes, innovations, and solutions
7 results for "treatment-resistant depression"
A quick, personalized brain stimulation therapy is now available in Arkansas for people whose depression hasn't responded to medication or counseling. The FDA-approved SAINT system at UAMS takes just five days and helps restore normal brain function.
Scientists discovered that a single dose of the psychedelic compound DMT produces longer-lasting antidepressant effects in mice than the currently approved rapid-acting treatment S-ketamine. This breakthrough could offer new hope for millions struggling with treatment-resistant depression.
New Mexico just set aside $630,000 to ensure low-income and rural residents can access groundbreaking psilocybin therapy for treatment-resistant depression and PTSD. The state is creating the nation's first medically integrated psilocybin program, launching by end of 2026.
A new UCLA study shows an intensive five-day magnetic brain stimulation protocol works as well as the traditional six-week treatment for depression. This breakthrough could help thousands of patients who struggle to commit to months of clinic visits.
A second major clinical trial shows psilocybin therapy significantly reduces treatment-resistant depression. The breakthrough brings new hope to millions who haven't found relief from traditional antidepressants.
A brief 25-minute psychedelic treatment lifted depression symptoms that lasted up to six months for people who hadn't found relief anywhere else. Just one dose of DMT helped patients who'd been struggling for an average of 10 years.
People with depression who haven't responded to medication found new hope through a strict low-carb diet in a groundbreaking Oxford study. The ketogenic approach delivered measurable improvements after just six weeks.